Observational studyBreast cancer research and treatment2025

Real-world clinical outcomes associated with first-line palbociclib and aromatase inhibitor therapy among patients with HR+/HER2- advanced breast cancer in Europe.

Olga Oikonomidou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.